262 related articles for article (PubMed ID: 34706731)
1. Perturbation of PI3K/Akt signaling affected autophagy modulation in dystrophin-deficient myoblasts.
Yazid MD; Hung-Chih C
Cell Commun Signal; 2021 Oct; 19(1):105. PubMed ID: 34706731
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
Siemionow M; Szilagyi E; Cwykiel J; Domaszewska-Szostek A; Heydemann A; Garcia-Martinez J; Siemionow K
Stem Cells Dev; 2021 Feb; 30(4):190-202. PubMed ID: 33349121
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.
Alexander MS; Casar JC; Motohashi N; Vieira NM; Eisenberg I; Marshall JL; Gasperini MJ; Lek A; Myers JA; Estrella EA; Kang PB; Shapiro F; Rahimov F; Kawahara G; Widrick JJ; Kunkel LM
J Clin Invest; 2014 Jun; 124(6):2651-67. PubMed ID: 24789910
[TBL] [Abstract][Full Text] [Related]
6. Loss of full-length dystrophin expression results in major cell-autonomous abnormalities in proliferating myoblasts.
Gosselin MRF; Mournetas V; Borczyk M; Verma S; Occhipinti A; Róg J; Bozycki L; Korostynski M; Robson SC; Angione C; Pinset C; Gorecki DC
Elife; 2022 Sep; 11():. PubMed ID: 36164827
[TBL] [Abstract][Full Text] [Related]
7. Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy.
van Westering TLE; Johansson HJ; Hanson B; Coenen-Stass AML; Lomonosova Y; Tanihata J; Motohashi N; Yokota T; Takeda S; Lehtiö J; Wood MJA; El Andaloussi S; Aoki Y; Roberts TC
Mol Cell Proteomics; 2020 Dec; 19(12):2047-2068. PubMed ID: 32994316
[TBL] [Abstract][Full Text] [Related]
8. Impaired regenerative capacity and lower revertant fibre expansion in dystrophin-deficient mdx muscles on DBA/2 background.
Rodrigues M; Echigoya Y; Maruyama R; Lim KR; Fukada SI; Yokota T
Sci Rep; 2016 Dec; 6():38371. PubMed ID: 27924830
[TBL] [Abstract][Full Text] [Related]
9. PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle.
Feron M; Guevel L; Rouger K; Dubreil L; Arnaud MC; Ledevin M; Megeney LA; Cherel Y; Sakanyan V
Am J Pathol; 2009 Apr; 174(4):1459-70. PubMed ID: 19264909
[TBL] [Abstract][Full Text] [Related]
10. Sertoli Cells Improve Myogenic Differentiation, Reduce Fibrogenic Markers, and Induce Utrophin Expression in Human DMD Myoblasts.
Salvadori L; Chiappalupi S; Arato I; Mancuso F; Calvitti M; Marchetti MC; Riuzzi F; Calafiore R; Luca G; Sorci G
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680138
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism of autophagic cell death in dystrophic muscle regulated by P2RX7 receptor large-pore formation and HSP90.
Young CN; Sinadinos A; Lefebvre A; Chan P; Arkle S; Vaudry D; Gorecki DC
Autophagy; 2015; 11(1):113-30. PubMed ID: 25700737
[TBL] [Abstract][Full Text] [Related]
12. Skeletal Muscle Differentiation on a Chip Shows Human Donor Mesoangioblasts' Efficiency in Restoring Dystrophin in a Duchenne Muscular Dystrophy Model.
Serena E; Zatti S; Zoso A; Lo Verso F; Tedesco FS; Cossu G; Elvassore N
Stem Cells Transl Med; 2016 Dec; 5(12):1676-1683. PubMed ID: 27502519
[TBL] [Abstract][Full Text] [Related]
13. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
[TBL] [Abstract][Full Text] [Related]
14. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.
Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA
BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246
[TBL] [Abstract][Full Text] [Related]
15. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.
Shu L; Houghton PJ
Mol Cell Biol; 2009 Sep; 29(17):4691-700. PubMed ID: 19564418
[TBL] [Abstract][Full Text] [Related]
16. Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch.
Dogra C; Changotra H; Wergedal JE; Kumar A
J Cell Physiol; 2006 Sep; 208(3):575-85. PubMed ID: 16741926
[TBL] [Abstract][Full Text] [Related]
17. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
[TBL] [Abstract][Full Text] [Related]
18. Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.
Meng J; Counsell JR; Reza M; Laval SH; Danos O; Thrasher A; Lochmüller H; Muntoni F; Morgan JE
Sci Rep; 2016 Jan; 6():19750. PubMed ID: 26813695
[TBL] [Abstract][Full Text] [Related]
19. Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy.
Boppart MD; Burkin DJ; Kaufman SJ
Biochim Biophys Acta; 2011 Apr; 1812(4):439-46. PubMed ID: 21216283
[TBL] [Abstract][Full Text] [Related]
20. Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy.
Niranjan N; Mareedu S; Tian Y; Kodippili K; Fefelova N; Voit A; Xie LH; Duan D; Babu GJ
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C813-C824. PubMed ID: 31365291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
